<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-42593" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neurothekeoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kao</surname>
            <given-names>Erica Y.</given-names>
          </name>
          <aff>Brooke Army Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kernig</surname>
            <given-names>Mikelle L.</given-names>
          </name>
          <aff>Uniformed Services University HS, SAMMC</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Erica Kao declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mikelle Kernig declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-42593.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Neurothekeomas are rare, benign, superficial cutaneous tumors with variable histologic patterns, including myxoid, cellular, or mixed-type, based primarily on the amount of myxoid matrix present. They frequently occur in the head and neck and affect females more often than males, usually in the second and early third decades of life. This activity illustrates the evaluation, treatment, and complications of neurothekeomas and the importance of an interprofessional team approach to management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the&#x000a0;etiology of a neurothekeoma.</p></list-item><list-item><p>Evaluate&#x000a0;the typical presentation of a neurothekeoma.</p></list-item><list-item><p>Determine&#x000a0;how to manage neurothekeomas.</p></list-item><list-item><p>Strategize with the interprofessional team to provide effective care to patients affected by neurothekeomas.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=42593&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=42593">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-42593.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Neurothekeomas are rare, benign, superficial soft tissue tumors that most commonly occur on the head and neck.&#x000a0;They affect females more often than males, usually in the second and early third decades of life.<xref ref-type="bibr" rid="article-42593.r1">[1]</xref>&#x000a0;Clinically, neurothekeomas present as a skin-colored, pink, red, or brown well-circumscribed papule or nodule. Usually, they are asymptomatic but may be accompanied by pain with pressure. Neurothekeomas have variable histologic patterns, including myxoid, cellular, or mixed-type, based primarily on the amount of myxoid matrix present. Because of overlapping clinical presentation and histology, nerve sheath myxoma has been inadvertently included within the myxoid variant of neurothekeoma. However, neurothekeoma, described by Barnhill and Mihm in 1990, appears to be a separate and distinct entity from true nerve sheath myxoma.<xref ref-type="bibr" rid="article-42593.r2">[2]</xref>&#x000a0;Rather than arising from peripheral nerve sheath, it has been postulated that neurothekeomas are of fibrohistiocytic derivation.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r5">[5]</xref><xref ref-type="bibr" rid="article-42593.r6">[6]</xref>&#x000a0;While nerve sheath myxoma demonstrates immunoreactivity for S100 protein, neurothekeoma fails to react with S100 regardless of the histologic pattern (myxoid, mixed, or cellular).</p>
      </sec>
      <sec id="article-42593.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There has been considerable confusion in characterizing and defining the origin of neurothekeomas. In 1980, Gallager and Helwig first classified neurothekeomas as dermal tumors of neural origin with characteristic clinical features and distinctive histology. Clinical features included a flesh-colored or slightly erythematous nodule of soft consistency located on the head, upper extremities, or trunk and arising more commonly in young females. Histologic features included spindled cells arranged in nests and cords with a mucinous, myxoid background containing dermal collagen bundles. Because the tumor cells appear similar to Schwann cells on electron microscopy (spindle-shaped and surrounded by a basement membrane without myofilament or melanosomes), the authors proposed "neurothekeoma" from the Greek word for sheath.<xref ref-type="bibr" rid="article-42593.r7">[7]</xref>&#x000a0;In 1986, Rosati et al reported cases of cellular neurothekeoma, believing them to be a cellular variant of the previously reported myxoid neurothekeoma.<xref ref-type="bibr" rid="article-42593.r8">[8]</xref>&#x000a0;In 1990, Barnhill and Mihm reported on several cases of cellular neurothekeoma, remarking on their histologic similarity to melanocytic tumors as well as commenting on their failure to react with S100 protein immunostain, unlike the original reported myxoid variant of neurothekeoma. Barnhill and Mihm suggested that cellular neurothekeoma represented a distinct subcategory of neurothekeoma and then, in 1991,&#x000a0;suggested that cellular neurothekeoma might present an entirely separate entity.<xref ref-type="bibr" rid="article-42593.r1">[1]</xref><xref ref-type="bibr" rid="article-42593.r9">[9]</xref>&#x000a0;It is recognized now that at least some of the cases reported by Gallager and Helwig in 1980, as well as some subsequent reports of neurothekeoma, represented dermal nerve sheath myxoma, an entity of peripheral nerve sheath derivation that shares overlapping clinical and histologic features with neurothekeoma.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r7">[7]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r10">[10]</xref>&#x000a0;In 2005, Fetsch et al reported on a series of nerve sheath myxomas, the corresponding characteristic immunoprofile, and the tendency of nerve sheath myxoma to arise in different locations and exhibit a higher recurrence rate than neurothekeoma.<xref ref-type="bibr" rid="article-42593.r11">[11]</xref>&#x000a0;In 2007, 2 large case studies of neurothekeomas were published separately by Fetsch et al and Hornick and Fletcher, detailing the immunoprofile of neurothekeoma, further defining the entity as distinctive and separate from nerve sheath myxoma.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref>&#x000a0;Rather than displaying nerve sheath differentiation, it has been postulated that neurothekeoma is fibrohistiocytic.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r5">[5]</xref><xref ref-type="bibr" rid="article-42593.r6">[6]</xref></p>
      </sec>
      <sec id="article-42593.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Epidemiologically, females outnumber males almost 2 to 1, and although a wide age range has been reported, the tumor displays a strong predilection for the second and third decades of life.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r10">[10]</xref><xref ref-type="bibr" rid="article-42593.r12">[12]</xref><xref ref-type="bibr" rid="article-42593.r13">[13]</xref></p>
      </sec>
      <sec id="article-42593.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Neurothekeomas are classified histologically as myxoid, cellular, or mixed, depending on the amount of myxoid matrix.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r5">[5]</xref><xref ref-type="bibr" rid="article-42593.r6">[6]</xref><xref ref-type="bibr" rid="article-42593.r13">[13]</xref><xref ref-type="bibr" rid="article-42593.r6">[6]</xref>&#x000a0;The classical cellular neurothekeoma is a relatively circumscribed and lobular lesion in the dermis, although the lesion's periphery may have an infiltrative border. It typically comprises nests of epithelioid to slightly spindled tumor cells with a subtle whorling pattern. The tumor cells have relatively abundant eosinophilic cytoplasm and round to oval nuclei with small pinpoint nucleoli.<xref ref-type="bibr" rid="article-42593.r2">[2]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r5">[5]</xref><xref ref-type="bibr" rid="article-42593.r7">[7]</xref><xref ref-type="bibr" rid="article-42593.r14">[14]</xref> By immunohistochemistry, cellular neurothekeomas are typically positive for vimentin, NKI-C3 (CD63), CD10, and Mit-F, and focal reactivity is noted for smooth muscle actin and CD68. They are negative for S100, glial fibrillary acidic protein, and Melan A.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r14">[14]</xref><xref ref-type="bibr" rid="article-42593.r15">[15]</xref></p>
      </sec>
      <sec id="article-42593.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Lesions are often a singular subcutaneous dome-shaped papule or nodule measuring less than 2 cm and may be skin-colored, pink to tan, or red to brown. Most lesions are asymptomatic, although some may present with pain upon pressure. The lesions grow slowly and are usually superficially located, with rare, deeper subcutaneous fat or skeletal muscle involvement.&#x000a0;The&#x000a0;head and neck are the most common locations, but neurothekeomas may also be seen on the shoulder or upper extremities.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r8">[8]</xref><xref ref-type="bibr" rid="article-42593.r13">[13]</xref><xref ref-type="bibr" rid="article-42593.r14">[14]</xref>&#x000a0;Mucosal involvement is rare.<xref ref-type="bibr" rid="article-42593.r16">[16]</xref></p>
      </sec>
      <sec id="article-42593.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Clinicopathologic correlation is required for the correct diagnosis of a neurothekeoma.&#x000a0;If the lesion appears very superficial, a shave biopsy may be appropriate; however, since these are usually dermal nodules with the possibility of deeper involvement, a deep punch, incisional, or excisional biopsy may be a better option.&#x000a0;The chosen skin biopsy technique varies depending on the size and location of the lesion. When the lesion is small, easily palpable, and not located in a cosmetically or functionally sensitive area, imaging is not generally necessary. There are no known pathognomic radiologic findings; computed tomography (CT), magnetic resonance (MR), and fluorodeoxyglucose&#x000a0;positron emission tomography (FDG PET) imaging may be helpful adjuncts for surgical planning and clinical correlation. However, histology remains the gold standard for diagnosis.<xref ref-type="bibr" rid="article-42593.r17">[17]</xref></p>
      </sec>
      <sec id="article-42593.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Surgical excision is the primary method of treatment.<xref ref-type="bibr" rid="article-42593.r18">[18]</xref>&#x000a0;There is no consensus on excision margin, but clear microscopic&#x000a0;margins and a few millimeters of grossly negative margins are sufficient.<xref ref-type="bibr" rid="article-42593.r18">[18]</xref>&#x000a0;If the neurothekeoma is located in a cosmetically sensitive area, Mohs micrographic surgery may be used to achieve margin control while sparing the normal surrounding tissue.<xref ref-type="bibr" rid="article-42593.r13">[13]</xref> While the majority of these tumors are small (less than 1 cm) and have relatively bland histology with scant to no cytologic atypia and minimal extension into surrounding fat or skeletal muscle, there have been reports of neurothekeomas displaying atypical features, increasing concern for aggressive potential.<xref ref-type="bibr" rid="article-42593.r15">[15]</xref><xref ref-type="bibr" rid="article-42593.r19">[19]</xref>&#x000a0;Reported atypical features include clinical size greater than 1 cm, cytologic atypia in the form of pleomorphism and increased mitotic activity, infiltration into skeletal muscle or subcutaneous fat, and vascular invasion. Regardless of atypical features, reported recurrence rates remain low following complete surgical excision.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r13">[13]</xref><xref ref-type="bibr" rid="article-42593.r15">[15]</xref><xref ref-type="bibr" rid="article-42593.r19">[19]</xref></p>
      </sec>
      <sec id="article-42593.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for an epithelioid mass in the head and neck region includes granular cell tumor, cellular neurothekeoma, nerve sheath myxoma, neurofibroma, schwannoma, benign fibrous histiocytoma, melanocytic lesions, for example, Spitz nevus or melanoma, and infection.<xref ref-type="bibr" rid="article-42593.r2">[2]</xref><xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref>&#x000a0;The absence of bacterial or fungal elements on routine and special stains can rule out infectious etiologies. Granular cell tumors typically are positive for S100 protein immunostain; therefore, this entity can be ruled out with a negative S100 stain. The remaining entities on the list are neural (neurofibroma, schwannoma, nerve sheath myxoma), fibrohistiocytic (neurothekeoma, fibrous histiocytoma), or melanocytic and can all present similarly as solitary masses. Furthermore, these entities may mimic each other histologically.</p>
        <p>Distinguishing neural and fibrohistiocytic lesions from malignancies like melanoma can be difficult given the variable presence of epithelioid cells arranged in a cheque-like architecture and given the potential presence of unusual features such as nuclear atypia, mitoses, and extension into fat or skeletal muscle.<xref ref-type="bibr" rid="article-42593.r2">[2]</xref><xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref>&#x000a0;Careful inspection of morphology can help distinguish fibrohistiocytic lesions from each other. For instance, recognizing at least focal areas of a nested growth pattern characteristic of conventional cellular neurothekeoma helps distinguish it from superficial angiomyxomas or benign fibrous histiocytomas, which lacks nests of tumor cells.<xref ref-type="bibr" rid="article-42593.r14">[14]</xref>&#x000a0;However, because of this nested growth pattern, a melanocytic tumor or Spitz nevus could still be considered in the differential. The immunoprofile is telling in these cases because cellular neurothekeomas are negative for S100 and melanocyte-specific markers such as Melan-A and HMB-45, unlike true melanocytic tumors.<xref ref-type="bibr" rid="article-42593.r14">[14]</xref></p>
        <p>The most problematic delineation is between cellular neurothekeoma and nerve sheath myxoma because of overlapping clinical presentation and histology. In the past, nerve sheath myxoma has been inadvertently included within the myxoid variant of neurothekeoma.<xref ref-type="bibr" rid="article-42593.r2">[2]</xref>&#x000a0; Immunohistochemistry helps distinguish true nerve sheath myxoma from neurothekeoma. Nerve sheath myxomas are consistently positive for S100 and negative for NKI-C3, whereas cellular neurothekeomas show the opposite immunostaining pattern of S100 negativity and NKI-C3 positivity.<xref ref-type="bibr" rid="article-42593.r2">[2]</xref><xref ref-type="bibr" rid="article-42593.r3">[3]</xref>&#x000a0;The other neural lesions on the differential (schwannoma and neurofibroma) can be differentiated via morphology and immunostaining. Schwannomas have a biphasic growth pattern and are positive for S100, GFAP, and EMA. Neurofibromas are positive for S100.</p>
      </sec>
      <sec id="article-42593.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>As neurothekeoma is considered a benign entity, the prognosis is excellent, with very low recurrence rates following complete surgical excision.<xref ref-type="bibr" rid="article-42593.r3">[3]</xref><xref ref-type="bibr" rid="article-42593.r4">[4]</xref><xref ref-type="bibr" rid="article-42593.r13">[13]</xref><xref ref-type="bibr" rid="article-42593.r15">[15]</xref><xref ref-type="bibr" rid="article-42593.r19">[19]</xref></p>
      </sec>
      <sec id="article-42593.s11" sec-type="Complications">
        <title>Complications</title>
        <p>As most neurothekeomas are confined within the dermis, complications are generally minor and cosmetic related to the surgical scar. For lesions with subcutaneous extension beyond the fat and into the skeletal muscle, there may be a risk of localized weakness related to the extent of musculature removed with excision.</p>
      </sec>
      <sec id="article-42593.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>As the pathogenesis of neurothekeoma remains unclear, patients can currently not receive guidance regarding the prevention of such lesions.</p>
      </sec>
      <sec id="article-42593.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>In conclusion, neurothekeomas are rare, superficial tumors most often arising in the head and neck, shoulder, or upper extremities of younger females. The tumors tend to be small, less than 2 cm, and histologically are composed of a mix of spindled and epithelioid cells set against a variably myxoid background stroma. The neoplastic cells are generally immunoreactive with CD10, CD68, MITF-1, and NKI-C3 and negative for NSE, S100 protein, or GFAP. The recommended treatment for neurothekeoma is complete surgical excision; recurrence rates are low even for tumors demonstrating atypical features. Head and neck surgeons and pathologists need to be aware of the presentation and clinical course of this uncommon lesion and its similarity to other benign and malignant tumors clinically and histologically to adequately manage patients and provide appropriate treatment options and follow-up care.</p>
      </sec>
      <sec id="article-42593.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Because neurothekeomas are benign entities curative with surgical excision, the best patient outcomes can be achieved with an interprofessional care team of radiologists, surgeons, pathologists, primary care providers, and nurses who are cognizant of the specific clinical presentation and characteristic patient demographics. This aids in early recognition and proper management of this lesion. Furthermore, neurothekeomas can masquerade as other more aggressive malignancies. Thus, recognizing the morphologic and biological spectrum of neurothekeoma and its variants helps the healthcare professional team render the most accurate diagnosis and, most importantly, for the patient's peace of mind.</p>
      </sec>
      <sec id="article-42593.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=42593&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=42593">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/nerve-health/neurothekeoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=42593">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/42593/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=42593">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-42593.s16">
        <title>References</title>
        <ref id="article-42593.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnhill</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Mihm</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Cellular neurothekeoma. A distinctive variant of neurothekeoma mimicking nevomelanocytic tumors.</article-title>
            <source>Am J Surg Pathol</source>
            <year>1990</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-20</page-range>
            <pub-id pub-id-type="pmid">2154139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almeida</surname>
                <given-names>TFA</given-names>
              </name>
              <name>
                <surname>Verli</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Dos Santos</surname>
                <given-names>CRR</given-names>
              </name>
              <name>
                <surname>Falci</surname>
                <given-names>SGM</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>LY</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>LKY</given-names>
              </name>
              <name>
                <surname>Mesquita</surname>
                <given-names>ATM</given-names>
              </name>
              <name>
                <surname>Le&#x000f3;n</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Multiple Desmoplastic Cellular Neurothekeomas in Child: Report of the First Oral Case and Review of the Literature.</article-title>
            <source>Head Neck Pathol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-81</page-range>
            <pub-id pub-id-type="pmid">28597210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fetsch</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Laskin</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Hallman</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lupton</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Miettinen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>7</issue>
            <fpage>1103</fpage>
            <page-range>1103-14</page-range>
            <pub-id pub-id-type="pmid">17592278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hornick</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Cellular neurothekeoma: detailed characterization in a series of 133 cases.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>329</fpage>
            <page-range>329-40</page-range>
            <pub-id pub-id-type="pmid">17325474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Page</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mihm</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Googe</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <article-title>Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma.</article-title>
            <source>Mod Pathol</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>230</fpage>
            <page-range>230-4</page-range>
            <pub-id pub-id-type="pmid">14685254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yun</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Won</surname>
                <given-names>YH</given-names>
              </name>
            </person-group>
            <article-title>Myxoid Cellular Neurothekeoma: A New Entity of S100-Negative, CD68-Positive Myxoid Neurothekeoma.</article-title>
            <source>Ann Dermatol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>510</fpage>
            <page-range>510-3</page-range>
            <pub-id pub-id-type="pmid">25143683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallager</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Helwig</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Neurothekeoma--a benign cutaneous tumor of neural origin.</article-title>
            <source>Am J Clin Pathol</source>
            <year>1980</year>
            <month>Dec</month>
            <volume>74</volume>
            <issue>6</issue>
            <fpage>759</fpage>
            <page-range>759-64</page-range>
            <pub-id pub-id-type="pmid">7446487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosati</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fratamico</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Eusebi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Cellular neurothekeoma.</article-title>
            <source>Appl Pathol</source>
            <year>1986</year>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>186</fpage>
            <page-range>186-91</page-range>
            <pub-id pub-id-type="pmid">3297114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnhill</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Dickersin</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Nickeleit</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bhan</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Muhlbauer</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Mihm</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical, and ultrastructural observations.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>1 Pt 1</issue>
            <fpage>80</fpage>
            <page-range>80-8</page-range>
            <pub-id pub-id-type="pmid">1880258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Jing</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Neurothekeomas of the thoracic and lumbar area in an adult man: A case report.</article-title>
            <source>Mol Clin Oncol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>156</fpage>
            <page-range>156-158</page-range>
            <pub-id pub-id-type="pmid">24649326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fetsch</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Laskin</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Miettinen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Nerve sheath myxoma: a clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>12</issue>
            <fpage>1615</fpage>
            <page-range>1615-24</page-range>
            <pub-id pub-id-type="pmid">16327434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suarez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>High</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical analysis of KBA.62 in 18 neurothekeomas: a potential marker for differentiating neurothekeoma, but a marker that may lead to confusion with melanocytic tumors.</article-title>
            <source>J Cutan Pathol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-41</page-range>
            <pub-id pub-id-type="pmid">24151815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ward</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Prieto</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chevray</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kronowitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sturgis</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Neurothekeoma.</article-title>
            <source>Otolaryngol Head Neck Surg</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>132</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-9</page-range>
            <pub-id pub-id-type="pmid">15632914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stratton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Billings</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Cellular neurothekeoma: analysis of 37 cases emphasizing atypical histologic features.</article-title>
            <source>Mod Pathol</source>
            <year>2014</year>
            <month>May</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>701</fpage>
            <page-range>701-10</page-range>
            <pub-id pub-id-type="pmid">24186141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Busam</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Mentzel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Colpaert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barnhill</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases.</article-title>
            <source>Am J Surg Pathol</source>
            <year>1998</year>
            <month>Sep</month>
            <volume>22</volume>
            <issue>9</issue>
            <fpage>1067</fpage>
            <page-range>1067-72</page-range>
            <pub-id pub-id-type="pmid">9737238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Emami</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zawawi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ywakim</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nahal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Oral cellular neurothekeoma.</article-title>
            <source>Case Rep Otolaryngol</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>935435</fpage>
            <pub-id pub-id-type="pmid">23691398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Neurothekeoma of the tongue: CT, MR, and FDG PET imaging findings.</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>9</issue>
            <fpage>1823</fpage>
            <page-range>1823-5</page-range>
            <pub-id pub-id-type="pmid">17032850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boukovalas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Boroumand</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cole</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Cellular Neurothekeoma: A Rare Tumor with a Common Clinical Presentation.</article-title>
            <source>Plast Reconstr Surg Glob Open</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>8</issue>
            <fpage>e1006</fpage>
            <pub-id pub-id-type="pmid">27622087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42593.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Rigby</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Orlando</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Atypical cellular neurothekeoma--a diagnosis to be aware of.</article-title>
            <source>J Plast Reconstr Aesthet Surg</source>
            <year>2008</year>
            <volume>61</volume>
            <issue>2</issue>
            <fpage>186</fpage>
            <page-range>186-8</page-range>
            <pub-id pub-id-type="pmid">17709307</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
